Replies to post #4069 on VistaGen Therapeutics Inc (VTGN)

[Full Contact Yoga]

When a drug doesn't work at all the stock price suffers. No one needs to know anything other than that really...plus, their recent offering capped their value at $1. It doesn't help that J and J just received FDA clearance for a similar treatment, nor does it imply AV-101 will help with MDD...bio stocks are a gamble, very few do anything of value, this may prove no different...and, of course, they will need more money soon, at a lower price point, not pretty...